Wyoming Medicaid Set To Cover Cognoa’s Canvas Dx Autism Diagnosis Tool

Behavioral health technology provider Cognoa said its FDA-approved autism diagnostic tool, Canvas Dx, was added as a;covered benefit under;Wyoming Medicaid. Use of the artificial intelligence (AI)-based diagnostic is expected to result in improved outcomes for children and families as well as reductions in overall health care utilization. ;

Canvas Dx is intended for use by health care professionals as an aid in the diagnosis of autism spectrum disorder (ASD) for children ages 18 months to six years.;The launch of Canvas Dx through Medicaid in the state is expected to make it easier . . .